Jame Medical Technologies Files IPO Prospectus Amid Consolidated Market Landscape in Multi-Billion-Dollar Medical Coating Industry

According to QYResearch’s “Analysis of the Global and Chinese Medical Coating Market Size, Industrial Chain, and Industry Development Trends,” the compound annual growth rate (CAGR) of global medical coating sales volume from 2017 to 2021 was approximately 6.25%, and the global medical coating market value is projected to reach US$1.419 billion by 2029, with an estimated CAGR of approximately 8.87%. Research indicates that jMedtech’s hydrophilic coating products have demonstrated outstanding market share performance.

Historically, this vast market was characterized by a clear import monopoly. In recent years, however, with the rise of innovation in China’s healthcare industry, numerous niche segments have achieved breakthroughs, giving rise to a cohort of competitive enterprises. The medical coatings sector is one such segment. Within this field, one company has frequently been featured in various research reports on medical coatings, making a significant contribution to the innovative development of China’s medical coatings industry.

This company is jMedtech, founded in Xiamen in 2014. Since its inception, how has jMedtech achieved significant progress in the field of medical coatings? Why did it expand into the business of medical tubing? From its perspective, what are the future development trends for medical coatings and medical tubing? With these questions in mind, VCBeat interviewed Zhang Ying, General Manager of jMedtech, to seek answers.

VCBeat: What challenges and opportunities did jMedtech face in its early stages of development?

jMedtech:During the early days of jMedtech, the domestic medical coating industry in China was still in its infancy, with locally produced medical coatings being virtually nonexistent. As one of the first providers of domestically produced medical coatings in China, we faced two major challenges: on one hand, the downstream market demand was immature due to the nascent stage of domestic medical devices, resulting in a limited customer base; on the other hand, in addition to rapidly developing relevant technologies, we had to compete directly with established overseas coating companies.

Subsequently, the gradual maturation of the downstream medical device market, coupled with customers’ increasing recognition of coating technologies and their industry value, created favorable conditions for jMedtech’s growth and drove us to continuously innovate and enhance our technical capabilities. Ultimately, jMedtech has emerged as a leader in the domestic medical coating sector.

VCBeat: It is understood that jMedtech’s Chinese entity was established in 2014. After more than a decade of development, in addition to its medical coating business, jMedtech has also expanded into the medical tubing sector. What are the underlying reasons for this strategic move?

jMedtech:This strategic move stems from our assessment of development trends in the healthcare industry. Initially, jMedtech focused on medical coating services, earning widespread market recognition through its technological expertise and quality advantages. However, through long-term, in-depth collaborations with clients, we observed a year-on-year increase in demand for high-performance medical tubing. Meanwhile, the domestic market for such high-performance medical tubing remained monopolized by overseas giants, leaving clients in need of localized supply chains and more responsive technical support. Leveraging our foundational technological accumulation in polymer materials, we were able to rapidly enter the field and master the core technologies of medical tubing. In summary, the emergence of market demand combined with our established expertise in polymer materials enabled us to launch our medical tubing business.

VCBeat: You just mentioned the driving role of changes in the external environment on jMedtech’s development. From an internal perspective, what characteristics of jMedtech have enabled it to overcome challenges and achieve substantial growth?

jMedtech:Technological innovation is the key. We have remained steadfast in our commitment to researching and developing globally leading materials and technologies to meet market demands for new materials and functionalities. Meanwhile, we adhere to a customer-centric approach, strengthening collaborative partnerships with clients and listening to their actual needs to provide personalized solutions. Through continuous R&D investment and deep cooperation with customers, we ensure that jMedtech remains at the forefront of technological innovation.

VCBeat: If you were to select two products that best represent jMedtech's technological innovation, which two would you choose?

jMedtech:At this stage, we focus on two core product solutions: first, an integrated solution for functional medical coatings and equipment; second, a high-performance medical tubing solution. This has enabled us to establish a full-industry-chain layout encompassing “materials–equipment–technology–services,” allowing us to provide customers with comprehensive medical material solutions.

In the field of medical coatings, jAqua^®Hydrophilic super-slippery coatings are our core products, and our coating technology holds significant advantages in the industry. Our hydrophilic coatings, applied in interventional procedures such as cardiovascular and urological surgeries, reduce resistance during medical operations, effectively minimize friction between catheters and vessel walls, lower the risk of vascular injury, exhibit strong adhesion with minimal delamination, and enhance the reliability and safety of medical devices. Notably, our metal coatings are a scarce offering in the market, providing superior performance and technologically advanced metal surface coating solutions. Most importantly, we customize coating solutions to meet diverse customer requirements, ensuring optimal performance for each client’s medical devices.

In the field of medical tubing, our core product is PTFE-lined tubing. jMedtech is one of the very few companies globally to achieve full coverage in terms of PTFE tubing types, manufacturing processes, and specifications. This means we can fully meet customer needs ranging from extremely small inner diameters to ultra-large pipe diameters. For instance, our PTFE free-extrusion lined tubing with a wall thickness of 0.0005” provides an ultra-thin wall for medical catheters. This design not only ensures excellent mechanical properties but also maximizes the internal lumen of the tubing. Such features are essential to meet the high demands of neuro-minimally invasive surgeries, where greater flexibility and a larger lumen are required for clinical applications.

VCBeat: In addition to the core products you mentioned above, what other product layouts has jMedtech completed?

jMedtech:Excluding jAqua^®In addition to hydrophilic super-slippery coatings and PTFE-lined tubes, we have established a diversified portfolio of medical functional coating materials and medical tubing materials. For instance, in the realm of medical functional coatings, we have also developed antibacterial coatings and anticoagulant coatings. The former effectively prevents bacterial colonization on devices and biofilm formation, thereby reducing the risk of device-related infections; the latter effectively inhibits blood coagulation on the surface of medical devices. For devices that require prolonged contact with blood, such as cardiovascular catheters and heart valves, anticoagulant functionality is critical, as it not only reduces the risk of thrombosis but also ensures treatment safety.

In the field of medical tubing, with a focus on the R&D and application of PTFE materials—including PTFE-lined tubes, PTFE thin-walled multi-lumen tubes, and PTFE zebra heat-shrinkable tubes—jMedtech has also expanded its portfolio to include medical heat-shrinkable tubes (such as FEP and Pebax heat-shrinkable tubes), medical extruded tubes, and medical polyimide (PI) tubes. The optional materials for medical extruded tubes encompass specialty materials like PPSU and PEEK, engineering plastics such as PEBAX and Nylon, and general-purpose materials including PE, PP, and PC. This diverse material portfolio, backed by robust technical capabilities, enables jMedtech to fully meet the diversified needs of its customers.

VCBeat: You have repeatedly emphasized being customer-oriented and meeting customers’ actual needs. In practice, how does jMedtech achieve this?

jMedtech:Yes, in fact, whether in our medical coating business or our medical tubing business, we consistently emphasize a customer-centric approach. Specifically, we provide comprehensive services to our clients, including material consultation, free sample delivery, rapid prototyping, technical support, technical training, and customized solutions. Throughout this process, we also gain an in-depth understanding of our customers’ needs to ensure that every stage delivers efficient and convenient solutions.

In addition, jMedtech has established a professional customer service team to ensure close communication with clients at every stage of the project. We place particular emphasis on after-sales service, providing ongoing technical support and quality assurance to help customers resolve issues encountered during application. Through these initiatives, jMedtech has not only established an advantage in product quality but also enhanced customer trust and satisfaction through high-quality service.

VCBeat: In addition to technological innovation and a customer-centric service philosophy, what other core competencies does jMedtech possess, and how have they contributed to the company's market expansion?

jMedtech:In addition to technological innovation and a customer-centric service philosophy, quality control is also paramount. We ensure that every batch of products meets high-quality standards through rigorous quality management. Furthermore, global layout and flexible market adaptability are key aspects of competitiveness; jMedtech has established a strong brand image and positive market reputation in multiple international markets.

VCBeat: A company’s positive development hinges on its grasp of industry trends. In your view, what emerging trends in the sector deserve attention?

jMedtech:I believe that the future development of medical coatings will focus on two key directions—personalized customization and multifunctionality—to drive innovation and application in medical devices. At the core of personalized customization is the provision of tailored coating solutions based on customer needs. Since each customer has different design requirements for catheters, coatings must be optimized according to specific clinical scenarios and technical specifications to ensure optimal performance across all aspects. Multifunctionality represents another significant trend in coating development. Future medical coatings will not be limited to a single function but will instead integrate multiple functionalities. For instance, hydrophilic anticoagulant coatings can effectively reduce friction between catheters and vessel walls, thereby lowering the risk of thrombosis; meanwhile, hydrophilic antibacterial coatings provide antimicrobial protection while reducing friction, thus decreasing the incidence of infection. Such multifunctional coatings will enable medical devices to better adapt to complex clinical demands, enhance performance during minimally invasive procedures and long-term use, and further advance the progress and innovation of medical coating technologies.

In the realm of medical tubing, advancements in materials science are driving future developments toward thinner, stronger, and more flexible designs to accommodate complex and precise medical applications. Thinner tubing provides a larger lumen space, reducing surgical invasiveness; greater strength ensures durability and safety, enabling the tubing to withstand higher tensile forces and pressure; and enhanced flexibility improves adaptability, allowing for flexible bending and improved operational precision. Such tubing will facilitate the advancement of minimally invasive surgery, enhance the performance of medical devices and patient comfort, and lay a solid foundation for precision medicine.

VCBeat: Based on these industry insights, what is jMedtech’s future development plan?

jMedtech:Our future roadmap focuses on three key areas. In terms of technological innovation, we will increase R&D investment in medical coatings, medical tubing, and polymer materials, while collaborating closely with innovative medical device companies to develop more groundbreaking and challenging products. Regarding product development, we will further enhance our technical advantages in coatings and tubing, expand application scenarios—particularly in neurointerventional and electrophysiology fields—and provide integrated solutions to improve the performance of medical devices. As for market expansion, we will accelerate penetration in the domestic market while actively exploring global markets such as Europe and the United States, leveraging our technological strengths and high-quality services to drive globalization.